ArticleCNS neuroscience & therapeutics2026
Deciphering the Impact of EPHA1-AS1 Gene Polymorphism on Social Cognition Deficits in Parkinson's Disease.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimsEphrin type-A receptor 1 (EPHA1) has been identified as a potential contributor to the pathogenesis of Parkinson's disease (PD). The complex interactions between PD symptoms and the EPHA1 protein warrant further exploration.
methodsA cohort of 509 participants, including 362 normal controls (NCs) and 147 PD patients, was included and genotyped for the ephrin type-A receptor 1-antisense 1 (EPHA1-AS1) gene. Overall and emotion-specific social cognition were assessed using the Reading the Mind in the Eyes Test. The relationship between the EPHA1-AS1 gene, PD, and social cognition was analyzed using the Mann-Whitney U test, the Quade test, and moderation analysis.
resultsCompared to NCs, PD patients showed markedly poorer social cognition, especially in overall and negative emotions, regardless of genotype. The rs2966700 variant significantly affects the positive subscore among all participants (p = 0.006), with TT carriers performing better. Furthermore, PD was a significant moderator of the association between rs2966700 and the positive subscore (p = 0.001), with PD patients carrying the C allele performing worse.
conclusionsThis study offers new insights into the interaction between the EPHA1-AS1 gene and PD, thereby enhancing our understanding of its impact on social cognition, particularly in recognizing positive emotions in individuals with PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.